ID

41219

Description

A Study of MabThera (Rituximab) Addition to Regularly Prescribed Chemotherapy in Patients With Untreated Mantle Cell Lymphoma.; ODM derived from: https://clinicaltrials.gov/show/NCT01144403

Link

https://clinicaltrials.gov/show/NCT01144403

Keywords

  1. 7/18/20 7/18/20 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

July 18, 2020

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :


    No comments

    In order to download data models you must be logged in. Please log in or register for free.

    Eligibility Lymphoma, B-Cell NCT01144403

    Eligibility Lymphoma, B-Cell NCT01144403

    Inclusion Criteria
    Description

    Inclusion Criteria

    Alias
    UMLS CUI
    C1512693
    adult patients, >/=18 years of age
    Description

    Adult | Age

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0001675
    UMLS CUI [2]
    C0001779
    untreated mantle cell lymphoma, not eligible for autologous stem cell transplantation
    Description

    Mantle cell lymphoma Untreated | Ineligibility Autologous hematopoietic stem cell transplant

    Data type

    boolean

    Alias
    UMLS CUI [1,1]
    C0334634
    UMLS CUI [1,2]
    C0332155
    UMLS CUI [2,1]
    C1512714
    UMLS CUI [2,2]
    C2193200
    known mantle cell lymphoma international prognostic index (mipi) at diagnosis
    Description

    MIPI - Mantle Cell Lymphoma International Prognostic Index

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C4706335
    ecog performance status 0-2
    Description

    ECOG performance status

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C1520224
    adequate hematological, renal and hepatic function
    Description

    Hematologic function | Renal function | Liver function

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0221130
    UMLS CUI [2]
    C0232804
    UMLS CUI [3]
    C0232741
    Exclusion Criteria
    Description

    Exclusion Criteria

    Alias
    UMLS CUI
    C0680251
    known hypersensitivity to murine proteins or chemotherapy regimen
    Description

    Hypersensitivity Murine protein | Hypersensitivity Chemotherapy

    Data type

    boolean

    Alias
    UMLS CUI [1,1]
    C0020517
    UMLS CUI [1,2]
    C1699668
    UMLS CUI [2,1]
    C0020517
    UMLS CUI [2,2]
    C0392920
    previous first-line therapy
    Description

    First line treatment Previous

    Data type

    boolean

    Alias
    UMLS CUI [1,1]
    C1708063
    UMLS CUI [1,2]
    C0205156
    history of other malignancy within the last 5 years, except for squamous cell carcinoma, basal cell carcinoma of the skin or in situ cervical carcinoma
    Description

    Cancer Other | Exception Squamous cell carcinoma | Exception Basal cell carcinoma | Exception Carcinoma in situ of uterine cervix

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C1707251
    UMLS CUI [2,1]
    C1705847
    UMLS CUI [2,2]
    C0007137
    UMLS CUI [3,1]
    C1705847
    UMLS CUI [3,2]
    C0007117
    UMLS CUI [4,1]
    C1705847
    UMLS CUI [4,2]
    C0851140
    active infection
    Description

    Communicable Disease

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0009450
    clinically significant cardiac disease
    Description

    Heart Disease

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0018799
    regular corticosteroid treatment in the 4 weeks prior to first dose of study drug
    Description

    Steroid therapy Regular

    Data type

    boolean

    Alias
    UMLS CUI [1,1]
    C0149783
    UMLS CUI [1,2]
    C0205272

    Similar models

    Eligibility Lymphoma, B-Cell NCT01144403

    Name
    Type
    Description | Question | Decode (Coded Value)
    Data type
    Alias
    Item Group
    C1512693 (UMLS CUI)
    Adult | Age
    Item
    adult patients, >/=18 years of age
    boolean
    C0001675 (UMLS CUI [1])
    C0001779 (UMLS CUI [2])
    Mantle cell lymphoma Untreated | Ineligibility Autologous hematopoietic stem cell transplant
    Item
    untreated mantle cell lymphoma, not eligible for autologous stem cell transplantation
    boolean
    C0334634 (UMLS CUI [1,1])
    C0332155 (UMLS CUI [1,2])
    C1512714 (UMLS CUI [2,1])
    C2193200 (UMLS CUI [2,2])
    MIPI - Mantle Cell Lymphoma International Prognostic Index
    Item
    known mantle cell lymphoma international prognostic index (mipi) at diagnosis
    boolean
    C4706335 (UMLS CUI [1])
    ECOG performance status
    Item
    ecog performance status 0-2
    boolean
    C1520224 (UMLS CUI [1])
    Hematologic function | Renal function | Liver function
    Item
    adequate hematological, renal and hepatic function
    boolean
    C0221130 (UMLS CUI [1])
    C0232804 (UMLS CUI [2])
    C0232741 (UMLS CUI [3])
    Item Group
    C0680251 (UMLS CUI)
    Hypersensitivity Murine protein | Hypersensitivity Chemotherapy
    Item
    known hypersensitivity to murine proteins or chemotherapy regimen
    boolean
    C0020517 (UMLS CUI [1,1])
    C1699668 (UMLS CUI [1,2])
    C0020517 (UMLS CUI [2,1])
    C0392920 (UMLS CUI [2,2])
    First line treatment Previous
    Item
    previous first-line therapy
    boolean
    C1708063 (UMLS CUI [1,1])
    C0205156 (UMLS CUI [1,2])
    Cancer Other | Exception Squamous cell carcinoma | Exception Basal cell carcinoma | Exception Carcinoma in situ of uterine cervix
    Item
    history of other malignancy within the last 5 years, except for squamous cell carcinoma, basal cell carcinoma of the skin or in situ cervical carcinoma
    boolean
    C1707251 (UMLS CUI [1])
    C1705847 (UMLS CUI [2,1])
    C0007137 (UMLS CUI [2,2])
    C1705847 (UMLS CUI [3,1])
    C0007117 (UMLS CUI [3,2])
    C1705847 (UMLS CUI [4,1])
    C0851140 (UMLS CUI [4,2])
    Communicable Disease
    Item
    active infection
    boolean
    C0009450 (UMLS CUI [1])
    Heart Disease
    Item
    clinically significant cardiac disease
    boolean
    C0018799 (UMLS CUI [1])
    Steroid therapy Regular
    Item
    regular corticosteroid treatment in the 4 weeks prior to first dose of study drug
    boolean
    C0149783 (UMLS CUI [1,1])
    C0205272 (UMLS CUI [1,2])

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial